Kurt Bestehorn

6.9k total citations · 1 hit paper
68 papers, 2.5k citations indexed

About

Kurt Bestehorn is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Epidemiology. According to data from OpenAlex, Kurt Bestehorn has authored 68 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Cardiology and Cardiovascular Medicine, 20 papers in Surgery and 15 papers in Epidemiology. Recurrent topics in Kurt Bestehorn's work include Lipoproteins and Cardiovascular Health (17 papers), Acute Myocardial Infarction Research (16 papers) and Cardiac Health and Mental Health (11 papers). Kurt Bestehorn is often cited by papers focused on Lipoproteins and Cardiovascular Health (17 papers), Acute Myocardial Infarction Research (16 papers) and Cardiac Health and Mental Health (11 papers). Kurt Bestehorn collaborates with scholars based in Germany, United States and Austria. Kurt Bestehorn's co-authors include Josép Brugada, Feifan Ouyang, Alexander Fürnkranz, Claudio Tondo, Thomas Arentz, Jean-Paul Albenque, Andreas Metzner, Stuart Pocock, Karl-Heinz Kuck and K. R. Julian Chun and has published in prestigious journals such as New England Journal of Medicine, European Heart Journal and BMC Public Health.

In The Last Decade

Kurt Bestehorn

67 papers receiving 2.4k citations

Hit Papers

Cryoballoon or Radiofrequency Ablation for Paroxysmal Atr... 2016 2026 2019 2022 2016 400 800 1.2k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Cryoballoon or Radiofrequency Ablation for Paroxysmal Atrial Fibrillation
    2016 1.3k citations Karl-Heinz Kuck, Josép Brugada et al. New England Journal of Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kurt Bestehorn Germany 21 1.9k 402 257 237 171 68 2.5k
Kevin L. Thomas United States 28 1.8k 1.0× 320 0.8× 219 0.9× 159 0.7× 87 0.5× 111 2.5k
Sue Hee Sung United States 21 1.1k 0.6× 231 0.6× 181 0.7× 137 0.6× 217 1.3× 65 1.6k
Alexander C. Fanaroff United States 20 942 0.5× 407 1.0× 265 1.0× 228 1.0× 84 0.5× 104 1.8k
Agustín Urrútia Spain 32 1.7k 0.9× 332 0.8× 179 0.7× 135 0.6× 108 0.6× 71 2.5k
Jorge Yarzebski United States 27 1.9k 1.0× 693 1.7× 225 0.9× 197 0.8× 51 0.3× 58 2.6k
Shuang Li United States 22 994 0.5× 742 1.8× 340 1.3× 277 1.2× 56 0.3× 67 1.8k
Magnus Janzon Sweden 25 1.6k 0.8× 711 1.8× 162 0.6× 466 2.0× 120 0.7× 87 2.2k
Marlous Hall United Kingdom 24 1.2k 0.6× 229 0.6× 306 1.2× 354 1.5× 81 0.5× 57 1.7k
Dragana Radovanović Switzerland 24 1.7k 0.9× 791 2.0× 218 0.8× 135 0.6× 55 0.3× 107 2.4k
Lisa A. Kaltenbach United States 30 1.1k 0.6× 624 1.6× 234 0.9× 176 0.7× 282 1.6× 76 2.2k

Countries citing papers authored by Kurt Bestehorn

Since Specialization
Citations

This map shows the geographic impact of Kurt Bestehorn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kurt Bestehorn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kurt Bestehorn more than expected).

Fields of papers citing papers by Kurt Bestehorn

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kurt Bestehorn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kurt Bestehorn. The network helps show where Kurt Bestehorn may publish in the future.

Co-authorship network of co-authors of Kurt Bestehorn

This figure shows the co-authorship network connecting the top 25 collaborators of Kurt Bestehorn. A scholar is included among the top collaborators of Kurt Bestehorn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kurt Bestehorn. Kurt Bestehorn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Schächinger, Volker, et al.. (2023). Healthcare provision of transcatheter aortic valve implantation in Germany. Herz. 48(6). 426–436. 1 indexed citations
2.
Bestehorn, Kurt, et al.. (2022). Transfemoral aortic valve implantation: procedural hospital volume and mortality in Germany. European Heart Journal. 44(10). 856–867. 6 indexed citations
3.
Bestehorn, Kurt, Bernhard Schwaab, & Axel Schlitt. (2022). Wie stark hat die COVID-19-Pandemie die kardiologische Rehabilitation im ersten Jahr der Pandemie beeinflusst? Ein Vergleich der Leistungszahlen aus 2019 mit 2020 in Deutschland. Zeitschrift für Evidenz Fortbildung und Qualität im Gesundheitswesen. 173. 22–26. 1 indexed citations
4.
Nechwatal, Robert, et al.. (2020). Nachsorge nach kathetergestütztem perkutanen Aortenklappenersatz (TAVI). Herz. 46(S1). 41–47. 1 indexed citations
5.
Kuck, Karl-Heinz, Josép Brugada, Alexander Fürnkranz, et al.. (2016). Cryoballoon or Radiofrequency Ablation for Paroxysmal Atrial Fibrillation. New England Journal of Medicine. 374(23). 2235–2245. 1296 indexed citations breakdown →
6.
7.
Diegeler, Anno, Brigitte Stiller, Eckart Fleck, et al.. (2015). German Heart Report 2013. The Thoracic and Cardiovascular Surgeon. 63(2). 86–96. 3 indexed citations
8.
Bestehorn, Kurt, et al.. (2015). Coronary procedures in German hospitals: a detailed analysis for specific patient clusters. Clinical Research in Cardiology. 104(7). 555–565. 8 indexed citations
9.
Witt, Sabine, Rolf Holle, Reiner Leidl, et al.. (2014). Should health insurers target prevention of cardiovascular disease?: a cost-effectiveness analysis of an individualised programme in Germany based on routine data. BMC Health Services Research. 14(1). 263–263. 11 indexed citations
10.
Pittrow, David, et al.. (2013). Lipid management in 13,000 high risk cardiovascular patients treated under daily practice conditions: LIMA Registry. Vascular Health and Risk Management. 9. 71–71. 9 indexed citations
11.
Reibis, Rona, et al.. (2012). Disparity in risk factor pattern in premature versus late-onset coronary artery disease: a survey of 15,381 patients. Vascular Health and Risk Management. 8. 473–473. 33 indexed citations
12.
Sonntag, Frank, et al.. (2012). Lipidtherapie im Alltag. DMW - Deutsche Medizinische Wochenschrift. 137(40). 2047–2052. 4 indexed citations
13.
Bestehorn, Kurt, et al.. (2011). Current state of cardiac rehabilitation in Germany: patient characteristics, risk factor management and control status, by education level. Vascular Health and Risk Management. 7. 639–639. 8 indexed citations
14.
Gitt, Anselm K., et al.. (2010). Prevalence and overlap of different lipid abnormalities in statin-treated patients at high cardiovascular risk in clinical practice in Germany. Clinical Research in Cardiology. 99(11). 723–733. 38 indexed citations
15.
Bestehorn, Kurt, et al.. (2010). Atherogenic dyslipidemia as evidenced by the lipid triad: prevalence and associated risk in statin-treated patients in ambulatory care. Current Medical Research and Opinion. 26(12). 2833–2839. 10 indexed citations
16.
Gitt, Anselm K., et al.. (2010). Adherence of hospital-based cardiologists to lipid guidelines in patients at high risk for cardiovascular events (2L registry). Clinical Research in Cardiology. 100(4). 277–287. 10 indexed citations
17.
Jünger, Claus, Bernhard Rauch, Steffen Schneider, et al.. (2010). Effect of early short-term cardiac rehabilitation after acute ST-elevation and non-ST-elevation myocardial infarction on 1-year mortality. Current Medical Research and Opinion. 26(4). 803–811. 37 indexed citations
18.
19.
Bestehorn, Kurt, Klaus W.J. Wahle, & Wilhelm Kirch. (2008). Stroke Risk Screening of Adults with Hypertension. Clinical Drug Investigation. 28(5). 281–289. 13 indexed citations
20.
Rodloff, Arne C., et al.. (1996). Vergleichende Untersuchung zum Kosten-/Effektivitäts-Verhältnis einer initialen Therapie mit Imipenem/Cilastatin bei der nosokomialen Pneumonie. AINS - Anästhesiologie · Intensivmedizin · Notfallmedizin · Schmerztherapie. 31(3). 172–180. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kevin L. Thomas Breakdown of academic impact, for papers by Sue Hee Sung Breakdown of academic impact, for papers by Alexander C. Fanaroff Breakdown of academic impact, for papers by Agustín Urrútia Breakdown of academic impact, for papers by Jorge Yarzebski Breakdown of academic impact, for papers by Shuang Li Breakdown of academic impact, for papers by Magnus Janzon Breakdown of academic impact, for papers by Marlous Hall Breakdown of academic impact, for papers by Dragana Radovanović Breakdown of academic impact, for papers by Lisa A. Kaltenbach
Rankless by CCL
2026